Accelerated ART Initiation for PWHIV Who Are Out of Care

Recruiting Phase 4 Interventional Study
HIV Infections ART Noncompliance, Patient
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Health Services Research
Participants needed
120 (estimated)
Sponsor
University of Missouri-Columbia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The main purpose of the study is to evaluate the effectiveness, of the ACCELERATE model of care to achieve HIV viral suppression at Week 24. The study will also assess the acceptability, appropriateness, feasibility, and sustainability of the ACCELERATE model of care. The ACCELERATE model combines a standardized method for outreach, the use of telehealth for rapid access to an HIV care provider, a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
PLWH Inclusion criteria: Participants must meet ALL the following inclusion criteria 1. 18 years or older at the time of obtaining the informed consent 2. Speaks English 3. Able to give consent which includes the ability to understand and comply with study requirements and instructions as judged by…
Contacts

Dima Dandachi, MD, MPH

(573) 882-7746

dandachid@health.missouri.edu

CONTACT

Hilal Abdessamad, MD

5735303333

hilal.abdessamad@health.missouri.edu

CONTACT